AstraZeneca Marks Milestone in SA Healthcare With Launch of Rare Disease Treatments for Children
Written by: BizCommunity Editor Save to Instapaper
The event included a panel discussion with experts from fields such as neuro-oncology, neurology, plastic surgery, and genetics.
Panellists highlighted the vital need for coordinated, specialist-driven care and robust collaboration across public and private sectors to ensure that patients receive integrated support at every stage of their journey.
Dr Nkuli Boikhutso, CEO of Nelson Mandela Children’s Hospital, stated: “We are honoured to be the site of this important milestone.
"AstraZeneca’s commitment to introducing new treatments for rare diseases offers hope for our young patients and aligns with our vision to provide world-class, specialised care for all children, regardless of their background.”
Rare diseases
Around the world, more than 400 million people are affected by over 10,000 known rare diseases, yet the vast majority of these conditions have no approved treatments.
For many rare disease patients and their families, this often results in years of uncertainty, misdiagnosis, and limited or difficult treatment options.
AstraZeneca is dedicated to transforming this landscape by introducing advanced therapies, supporting earlier and more accurate diagnoses, and fostering multidisciplinary collaboration.
“AstraZeneca’s entry into the rare disease space in South Africa is both a proud and hopeful moment for us,” said Deepak Arora, African cluster country president at AstraZeneca.
“Building on decades of pioneering rare disease science, we are committed to expanding access to transformational medicines for conditions such as NF1, PNH.
“This marks a significant milestone in our mission to improve the lives of patients living with rare diseases, especially children who have had very few options until now.”
AstraZeneca’s rare disease strategy in Africa is anchored in three key priorities: accelerating access to vital medicines, driving innovation through research and development, and expanding its global reach to make meaningful change.
Get new press articles by email
We submit and automate press releases distribution for a range of clients. Our platform brings in automation to 5 social media platforms with engaging hashtags. Our new platform The Pulse, allows premium PR Agencies to have access to our newsletter subscribers.
Latest from
- 7 Business Trends Your SME Can Leverage In 2026
- Sadilar Amplifies Visibility And Impact During Conference Season
- Future-ready Logistics- 5 Shifts TO Watch In 2026 (SUB-saharan Africa)
- Dunlop Urges Motorists To Prioritise Tyre Safety On The Busy Joburg To Cape Town Festive Route
- Poverty Trends Report Shows National Progress But Flags Growing Challenges In Gauteng
- SDG Challenge SA 2025 Highlights The Power Of Youth Innovation In Shaping A Sustainable Future
- Experienced Industry Leader Pauli Van Dyk Named Dean Of AFDA’s Upcoming Hatfield Campus
- South Africans Keep Tourism Alive As Homegrown Travel And Local Spending Rise
- Pretoria Student Wins Global Excel Esports Competition
- AfDB Steps Up Support For Somalia With $76m Investment In Roads And Regional Integration
- Corporate Law Experts Warn Directors Of Serious Consequences For Improper Transaction Approval
- New 3% Inflation Target Begins To Shift Expectations In South African Economy
- Retail As A Development Catalyst Drives New Africa Developments’ Inclusive Growth Strategy
- Collaborative SEF Model Shows How Civil Society And State Can Rebuild Economic Trust
- Shumani Accelerates Industrial Growth With Bheka Forklifts And New Equipment Plans For 2026
The Pulse Latest Articles
- Education Is The Frontline Of Inequality, Business Must Show Up (December 11, 2025)
- When The Purple Profile Pictures Fade, The Real Work Begins (December 11, 2025)
- Dear Santa, Please Skip The Socks This Year (December 10, 2025)
- Brandtech+ Has 100 Global Creative Roles For South African Talent (December 9, 2025)
- The Woman Behind Bertie: Michelle’s Journey To Cape Town’s Beloved Mobile Café (December 9, 2025)
